usecasehitident
Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
usecasehitident [2013/10/09 08:39] – rkiss | usecasehitident [2013/10/09 19:54] – rkiss | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== | + | ====== |
[[http:// | [[http:// | ||
- | You can identify new inhibitors/ | + | You can identify new inhibitors/ |
**__[[usecasestrbased|Structure-based virtual screening >> | **__[[usecasestrbased|Structure-based virtual screening >> | ||
Line 9: | Line 9: | ||
**__[[usecaseligbased|Ligand-based virtual screening >> | **__[[usecaseligbased|Ligand-based virtual screening >> | ||
- | + | -- | |
- | ====== Ligand-based virtual screening ====== | + | |
- | + | ||
- | Ligand-based virtual screening does not utilize the 3D structure of the target when searching for new hits. Instead, it is based on the structure of a reference ligand (endogenous ligand, known inhibitor, etc.) that binds to a target and/or exhibits some beneficial effect. In ligand-based virtual screening, compounds are typically ranked based on the similarity to the reference ligand (query). | + | |
**__[[usecases|Go back to use cases >> | **__[[usecases|Go back to use cases >> |
usecasehitident.txt · Last modified: 2014/01/01 15:49 by flack